An independent evaluation of the South African government's test project to reduce the risk of mother-to-child HIV transmission through the use of the antiretroviral drug nevirapine, endorses nationwide expansion of the project but acknowledges that the government has "valid concerns" about how the drug is administered, the Associated Press reports.